MedImmune Targets 5 PDL Patents In Licensing Spat
MedImmune LLC is seeking the invalidation of five patents owned by PDL BioPharma Inc. as part of a licensing fight over a respiratory drug for infants and a related product that...To view the full article, register now.
Already a subscriber? Click here to view full article